seres therapeutics stock forecast

For Seres Therapeutics stock forecast for 2027 5 year 12 predictions are offered for each month of 2027 with average Seres Therapeutics stock forecast of 4407 a high. MCRB analyst stock forecast price target and recommendation trends with.

3lnjqbhfpd8acm

On average Wall Street analysts predict.

. 151 rows About the Seres Therapeutics Inc. MCRB stock quote history news and other vital information to help you with your stock trading and investing. Stock Price Forecast The 8 analysts offering 12-month price forecasts for Seres Therapeutics Inc have a median target of 1750 with a high estimate of 3200 and a low estimate of 700.

MCRB stock forecast and price target. Seres Therapeutics stock price target cut to 13 from 44 at BofA Merrill Lynch Aug. Seres Therapeutics Inc MCRB Stock Forecast By Analysts.

Seres Therapeutics Inc Stock Forecast Over the next 52 weeks Seres Therapeutics Inc has on average historically risen by 100 based on the past 5 years of stock performance. This page was last updated on 2232022 by. Ad With Best-in-Class Trading Tools No Hidden Fees Trading Anywhere Else Would be Settling.

If you had invested in Seres Therapeutics stock at 5140 your return over the last 6 years. Seres Therapeutics stock was trading at 264 on March 11th 2020 when COVID-19 reached pandemic status according to the World Health Organization. 34 rows Given the current short-term trend the stock is expected to fall.

1 2016 at 1111 am. Stock forecast As of 2022 February 18 Friday. 1 day and price target of 856 USD.

ET by Tomi Kilgore Seres Therapeutics downgraded to neutral from buy at BofA. SERES THERAPEUTICS INC stock price forecast for further price development up to 893 time horizon. Based on our forecasts a long-term increase is expected the MCRB stock price prognosis for 2027-02-17 is 25418 USD.

And has now fallen 3 days in a row. During the day the stock. The average Seres Therapeutics stock price prediction forecasts a potential.

Analysts Recommendations for Seres Therapeutics Inc MCRB is based on 15 Institutional Analyst Ratings where 4667 are. Seres Therapeutics Inc quote is equal to 8070 USD at 2022-02-21. The stock price of Seres Therapeutics a small late stage clinical biotechnology company with a market cap of around 1 billion is up a whopping 77 in a month while it is up.

Find the latest Seres Therapeutics Inc. Summary of all time highs changes and price drops for Seres Therapeutics. Stock was originally listed at a price of 5140 in Jun 26 2015.

Find the latest Seres Therapeutics Inc. The Seres Therapeutics stock price fell by -207 on the last day Friday 18th Feb 2022 from 822 to 805. According to analysts Seres Therapeuticss stock has a predicted upside of 16130 based on their 12-month price targets.

That Seres Therapeuticss share price could reach 2083 by Jul 23 2022.

What You Need To Know About Seres Therapeutics Inc S Nasdaq Mcrb Investor Composition Nasdaq

Analysts Estimate Seres Therapeutics Mcrb To Report A Decline In Earnings What To Look Out For

Seres Therapeutics Mcrb Stock Price News Info The Motley Fool

19 48 Million In Sales Expected For Seres Therapeutics Inc Nasdaq Mcrb This Quarter Marketbeat

What You Need To Know About Seres Therapeutics Inc S Nasdaq Mcrb Investor Composition Nasdaq

Seres Therapeutics Price Target Analyst Ratings Nasdaq Mcrb

Self Healing Materials Market Analysis Report Global Industry Outlook Market Size Growth Prospects 2014 To 2025 Mil Marketing Insight Developed Economy